• Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Retroscreen Virology Group PLC

+ Add to Watchlist

RVG:LN

250.000 GBp 0.0000.00%

As of 11:35:07 ET on 12/18/2014.

Snapshot for Retroscreen Virology Group PLC (RVG)

Open: 250.000 Day's Range: 250.000 - 250.000 Volume: 0
Previous Close: 250.000 52wk Range: 231.000 - 330.000 1-Yr Rtn: -16.94%

Stock Chart for RVG

No chart data available.
  • RVG:LN 250.000
  • 1D
  • 1M
  • 1Y
250.000
Interactive RVG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RVG

Current P/E Ratio (ttm) 78.1250
Estimated P/E(12/2014) -
Relative P/E vs. UKX 4.3394
Earnings Per Share (GBP) (ttm) 0.0320
Est. EPS (GBP) (12/2014) -0.2470
Est. PEG Ratio -
Market Cap (M GBP) 169.13
Shares Outstanding (M) 67.65
30 Day Average Volume 13,650
Price/Book (mrq) 3.1341
Price/Sale (ttm) 4.3619
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RVG

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for RVG

Retroscreen Virology Group PLC conducts bio-medical services. The Company focuses on creating the next generation of antiviral drugs and vaccines for the treatment of a number of viral infections as well as carries out laboratory-based pre-clinical work on behalf of its pharmaceutical company clients. Retroscreen Virology serves clients throughout the world.

Kym Lynn DennyChief Executive OfficerGraham Edward YeatmanFinance Director/Secretary
More Company Profile & Key Executives for RVG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil